About Dr. Deepak Charles
Dr. Deepak Charles is a leading Haemato-Oncologist in India, with extensive training in the comprehensive management of malignant and non-malignant blood disorders. His areas of expertise include aplastic anaemia, stem cell transplants, and complex bone marrow disorders. He is particularly adept at treating myeloproliferative neoplasms, a group of rare blood cancers. Dr. Charles brings a wealth of experience from prestigious institutions and is dedicated to providing patient-centred care with a focus on advanced treatments.
Qualifications & Credentials
- MBBS from Government Medical College, Thrissur
- MD (Internal Medicine) from Government Medical College, Calicut
- DM (Clinical Haematology) from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry
- Training in Haematology at Christian Medical College (CMC), Vellore
- Training in Haematology at the All India Institute of Medical Sciences (AIIMS), New Delhi
Areas of Expertise
- Leukaemia
- Lymphoma
- Multiple Myeloma
- Myeloproliferative Neoplasms (MPN)
- Myelodysplastic Syndromes (MDS)
- Clinical Haematology
- Haemato-Oncology
- Bone Marrow Transplantation (BMT)
- Management of Aplastic Anaemia
- Stem Cell Transplants
- Bone Marrow Biopsy
- Stem Cell Harvest
- Chemotherapy for haematological malignancies
- Immunotherapy
- Targeted Therapy
List of Disease and Treatment for which Dr. Deepak Charles can be consulted
Professional Experience
- Current Affiliations: Senior Consultant, Aster Medcity Kochi (Oct 2016 - Present)
- Past Affiliations: Senior Resident, Jawaharlal Institute Of Postgraduate Medical Education And Research (JIPMER), Puducherry (Aug 2013 - Aug 2016)
- Trained undergraduates at JIPMER and Government Medical Colleges (Thrissur & Calicut)
- Comprehensive management of malignant and non-malignant disorders of the blood.
- Specialised training from renowned institutions like CMC Vellore and AIIMS, New Delhi.
Awards & Recognitions
- Attended the ASH Highlight meeting held at Bangkok, Thailand
Research & Publications
- "18F FDG PET/CT in a Rare Case of Erdheim–Chester Disease with Extensive Cutaneous and Skeletal Involvement," Indian Journal of Nuclear Medicine (August 2025)
- "Metachronous Occurrence of Acute Myeloid Leukaemia in a Case of Neuroendocrine Tumour," European Journal of Case Reports in Internal Medicine (March 2025)
- "Vaccine-induced Thrombotic Thrombocytopenia and Graft Thrombosis in a Renal Transplant Recipient," Indian Journal of Transplantation (September 2024)
Patient Success Stories & Testimonials
Treatment Approach & Philosophy
Treatment Costs
Treatment Type | Cost in INR (Approx.) | Cost in USD (Approx.) |
Leukaemia Treatment (Chemotherapy) | 5,00,000 - 15,00,000 | 6,000 - 18,000 |
Lymphoma Treatment (Chemotherapy) | 4,00,000 - 12,00,000 | 5,000 - 15,000 |
Bone Marrow Transplant (Autologous) | 15,00,000 - 30,00,000 | 18,000 - 36,000 |
Bone Marrow Transplant (Allogeneic) | 30,00,000 - 60,00,000 | 36,000 - 72,000 |
Aplastic Anaemia Management | 3,00,000 - 10,00,000 | 3,600 - 12,000 |
Myeloproliferative Neoplasm Treatment | 3,00,000 - 10,00,000 | 3,600 - 12,000 |